De Novo T790M Mutation in an L858R Epidermal Growth Factor Receptor Mutant-Associated Lung Adenocarcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
De Novo T790M Mutation in an L858R Epidermal Growth Factor Receptor Mutant-Associated Lung Adenocarcinoma
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 10, Pages 3074
Publisher
MDPI AG
Online
2020-10-23
DOI
10.3390/cancers12103074
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long Non-coding RNAs Involved in Resistance to Chemotherapy in Ovarian Cancer
- (2020) Cecilie Abildgaard et al. Frontiers in Oncology
- A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis
- (2020) Corina N. D’Alessandro-Gabazza et al. Nature Communications
- Understanding Lineage Plasticity as a Path to Targeted Therapy Failure in EGFR-Mutant Non-small Cell Lung Cancer
- (2020) Tatiana Shaurova et al. Frontiers in Genetics
- Structure and Dynamics of the EGF Receptor as Revealed by Experiments and Simulations and Its Relevance to Non-Small Cell Lung Cancer
- (2019) Marisa L. Martin-Fernandez et al. Cells
- miRNA–mRNA Associated With Survival in Endometrial Cancer
- (2019) Xiaofeng Xu et al. Frontiers in Genetics
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Long Non-coding RNA DLEU1 Promotes Proliferation and Invasion by Interacting With miR-381 and Enhancing HOXA13 Expression in Cervical Cancer
- (2018) Chang Liu et al. Frontiers in Genetics
- Clinicopathologic Features of Advanced Squamous NSCLC
- (2016) Mark A. Socinski et al. Journal of Thoracic Oncology
- Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
- (2016) Aaron N Hata et al. NATURE MEDICINE
- Genomic Alterations of Non-Coding Regions Underlie Human Cancer: Lessons from T-ALL
- (2016) Adrian Rivera-Reyes et al. TRENDS IN MOLECULAR MEDICINE
- Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
- (2016) Michael Ramirez et al. Nature Communications
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Genomic alterations in lung adenocarcinoma
- (2015) Siddhartha Devarakonda et al. LANCET ONCOLOGY
- Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
- (2015) Derek A. Oldridge et al. NATURE
- Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
- (2013) H. A. Yu et al. CLINICAL CANCER RESEARCH
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Development and Preclinical Efficacy of Novel Transforming Growth Factor-β1 Short Interfering RNAs for Pulmonary Fibrosis
- (2011) Corina N. D'Alessandro-Gabazza et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
- (2008) C.-H. Yun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started